Loading ETF profile…
LFSC seeks to invest in innovative life sciences companies that are expected to create value and long-term growth. The actively managed fund relies on a specialized and experienced team to research complex life sciences companies. It invests in US equity securities identified to have growth potential that meet the criteria of technological advancement, market disruption, or artificial intelligence. The broad life science field includes biotechnology, pharmaceutical, medical diagnostics and devices, healthcare services and technologies, and synthetic biology. Stock selection employs an extensive 10-step research process that includes reviews of publicly available and third-party information, peer reviews, financial and valuation models, internal research, surveys, as well as interviews and contact with management, industry and medical professionals, supply chain, and collaboration within the investment team. The fund may invest up to 20% in foreign companies listed on a US exchange.
بيانات التوزيع القطاعي غير متوفرة لهذا الصندوق بعد.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 7.94% | $9.73M |
| COGT | Cogent Biosciences Inc | 7.18% | $8.80M |
| LIVN | LivaNova PLC | 6.89% | $8.44M |
| SYRE | Spyre Therapeutics Inc | 6.72% | $8.23M |
| GH | Guardant Health Inc | 6.30% | $7.72M |
| CORT | Corcept Therapeutics Inc | 5.29% | $6.48M |
| MIRM | Mirum Pharmaceuticals Inc | 5.06% | $6.20M |
| BLLN | Billiontoone Inc | 4.35% | $5.33M |
| CYTK | Cytokinetics Inc | 4.24% | $5.19M |
| MANE | VeraDermics Inc | 3.77% | $4.62M |
| UTHR | United Therapeutics Corp | 3.54% | $4.34M |
| TRVI | Trevi Therapeutics Inc | 3.37% | $4.12M |
| SVRA | Savara Inc | 3.26% | $3.99M |
| NKTR | Nektar Therapeutics | 2.70% | $3.31M |
| DNTH | Dianthus Therapeutics Inc | 2.60% | $3.18M |
| AXSM | Axsome Therapeutics Inc | 2.53% | $3.10M |
| TMDX | TransMedics Group Inc | 2.35% | $2.87M |
| VRDN | Viridian Therapeutics Inc | 2.03% | $2.49M |
| CRVS | Corvus Pharmaceuticals Inc | 2.01% | $2.47M |
| ICUI | ICU Medical Inc | 1.99% | $2.44M |
| PVLA | Palvella Therapeutics Inc | 1.97% | $2.41M |
| TWST | Twist Bioscience Corp | 1.51% | $1.85M |
| CBLL | Ceribell Inc | 1.46% | $1.79M |
| HNGE | Hinge Health Inc | 1.23% | $1.51M |
| BBIO | Bridgebio Pharma Inc | 1.14% | $1.40M |